Navigation Links
New Kalorama Report Says In Vitro Diagnostic Market Reaches 54.6 Billion

NEW YORK, Aug. 14, 2014 /PRNewswire/ -- The world market for diagnostics is estimated at $54.6 billion in 2013, according to Kalorama Information.  The market is expected to grow 4% annually and reach $65 billion by 2018.  This includes all laboratory and hospital-based products, and OTC product sales.  Kalorama revealed the market estimates in its biennial survey of the IVD industry, The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition

The survey can be obtained at

New technology is leading the charge, according to Kalorama.  Diagnostic laboratory technology has changed dramatically in the past few years, due to the publication of the human genome project and advances in functional genomics, bioinformatics, miniaturization and microelectronics. 

"Not three years ago it would have been almost inconceivable to see research technologies such as genome sequencing and mass spectroscopy play a pivotal role in improving lab medicine," said Shara Rosen, Kalorama's lead diagnostic analyst and the author of the report.  "Their influence is felt in personalized medicine, inherited diseases, pathogen detection, antibiotic resistance testing, blood banking and much more to come."

According to the report, this phenomenon has seen the major vendors of these technologies enter the IVD market.  Life Technologies, Illumina, Affymetrix, Bruker Daltonics, PerkinElmer/Caliper and others have all launched clinical tests and test services.

Another finding in the report is that emerging markets have taken off.  All of the major IVD companies reported at least 25% increase in their sales in China and growth in the top seven emerging markets: Brazil, Turkey, Korea, India, Russia and Mexico. 

"We knew that these were target markets but the double-digit results in China were surprising," said Bruce Carlson, Publisher of Kalorama Information.  "These countries continue to invest in healthcare infrastructure and insurance coverage and IVD is part of that."

On the supply side, labs are challenged to add new tests with little increase in financial and human resources.  For most labs it may even mean doing more with less.

The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition presents the trends, technologies, customer needs and major suppliers with an eye on how they are shaping the IVD industry.  The survey can be found along with other industry renowned research from Kalorama at

About Kalorama Information -- Kalorama Information, a division of, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog.

Bruce Carlson

Logo -


SOURCE Kalorama Information
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Kalorama Report: Advanced Wound Care Products Market Nears 19 Billion
2. Kalorama: Billion-dollar Plus Market for Flow Cytometry Used in Clinical Testing
3. Kalorama: Antibiotic Drug Resistance Leads to HAI Deaths
4. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
5. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
6. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
7. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
8. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
9. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
10. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
11. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
Post Your Comments:
(Date:12/1/2015)... a leader in intelligent sensors and analytic software for sensor network-based systems, announced the OS-3008 ... of vital signs. Photo - ... ... ... This ...
(Date:12/1/2015)... Dec. 1, 2015  ImmunoCellular Therapeutics, Ltd. ... Andrew Gengos , President and Chief Executive ... December 3, 2015. Mr. Gengos plans to ... program in patients with newly diagnosed glioblastoma ... TIME:    12:15p.m. ET/9:15a.m. PT LINK: ...
(Date:12/1/2015)... December 1, 2015 ... addition of the  "2016 Shigella Testing ... Technologies, Competitive Strategies, Emerging Opportunities--US, Europe ...  report to their offering. --> ... addition of the  "2016 Shigella Testing ...
Breaking Medicine Technology:
(Date:12/1/2015)... , ... December 01, 2015 , ... ... it has been selected as a finalist in this year’s Fierce Innovation Awards: ... Next IT Healthcare was recognized as a finalist in the category of Digital ...
(Date:12/1/2015)... CA (PRWEB) , ... December 01, 2015 , ... ... and clinical solutions for the care management and population health arenas, is pleased ... providing clinical and cost containment services, has successfully implemented the ACUITY Complete Care™ ...
(Date:12/1/2015)... Atlanta, GA (PRWEB) , ... December 01, 2015 ... ... manufacturing, supports SACC-GA and SACC-USA through membership and leadership since 2008. ... and Chair for SACC-USA . Gary has spent a significant amount of ...
(Date:12/1/2015)... ... December 01, 2015 , ... Dr. ... a Modern Man for 2015. , Angeleno Magazine is a division of ... Established in 1994, Modern Luxury includes more than 50 magazine titles across 15 ...
(Date:11/30/2015)... ... November 30, 2015 , ... Third Molar SEO ... it has officially launched a sleek, mobile-ready and user-centric redesigned website. , Vivek ... website clearly outlines the benefits that its SEO services provide to dentists and ...
Breaking Medicine News(10 mins):